Page last updated: 2024-08-16

triazolam and dronabinol

triazolam has been researched along with dronabinol in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (70.00)	29.6817
2010's	3 (30.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Lombardo, F; Obach, RS; Waters, NJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Baudry, F; Douceron, H; Hassnaoui, S; Marc, B; Vaquero, P; Zerrouki, L	1
Hays, LR; Kelly, TH; Lile, JA; Pinsky, DJ	1
Hays, LR; Kelly, TH; Lile, JA	1

Reviews

1 review(s) available for triazolam and dronabinol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for triazolam and dronabinol

Article	Year
The reinforcing, self-reported performance and physiological effects of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users. Behavioural pharmacology, 2010, Volume: 21, Issue:1 Topics: Adult; Analgesics, Opioid; Blood Pressure; Body Temperature; Choice Behavior; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Dronabinol; Drug Users; Female; GABA Modulators; Heart Rate; Humans; Hydromorphone; Male; Marijuana Smoking; Methylphenidate; Psychomotor Performance; Reinforcement, Psychology; Respiration; Skin Temperature; Triazolam	2010

Article

Year

The reinforcing, self-reported performance and physiological effects of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users.

Behavioural pharmacology, 2010, Volume: 21, Issue:1

Topics: Adult; Analgesics, Opioid; Blood Pressure; Body Temperature; Choice Behavior; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Dronabinol; Drug Users; Female; GABA Modulators; Heart Rate; Humans; Hydromorphone; Male; Marijuana Smoking; Methylphenidate; Psychomotor Performance; Reinforcement, Psychology; Respiration; Skin Temperature; Triazolam

2010

Other Studies

8 other study(ies) available for triazolam and dronabinol

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Sexual assault under benzodiazepine submission in a Paris suburb. Archives of gynecology and obstetrics, 2000, Volume: 263, Issue:4 Topics: Adolescent; Adult; Anti-Anxiety Agents; Benzodiazepines; Cocaine; Dronabinol; Estazolam; Female; Flunitrazepam; Humans; Hypnotics and Sedatives; Immunoassay; Lorazepam; Male; Morphine; Narcotics; Nitrazepam; Paris; Rape; Retrospective Studies; Substance-Related Disorders; Temazepam; Time Factors; Triazolam	2000
Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol. Psychopharmacology, 2009, Volume: 203, Issue:2 Topics: Administration, Oral; Adult; Case-Control Studies; Discrimination, Psychological; Double-Blind Method; Dronabinol; Female; Humans; Hydromorphone; Male; Marijuana Abuse; Methylphenidate; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Surveys and Questionnaires; Triazolam; Young Adult	2009